Published in Br J Cancer on January 05, 2001
Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev (2012) 6.12
DDT Exposure in Utero and Breast Cancer. J Clin Endocrinol Metab (2015) 3.41
An evaluation of evidence for the carcinogenic activity of bisphenol A. Reprod Toxicol (2007) 1.83
Environmental exposures and mammary gland development: state of the science, public health implications, and research recommendations. Environ Health Perspect (2011) 1.71
Do parents of children with congenital malformations have a higher cancer risk? A nationwide study in Denmark. Br J Cancer (2002) 1.59
Environmental pollutants and breast cancer. Environ Health Perspect (2003) 1.53
LncRNA HOTAIR: A master regulator of chromatin dynamics and cancer. Biochim Biophys Acta (2015) 1.21
Fundamental flaws of hormesis for public health decisions. Environ Health Perspect (2005) 1.11
Pregnancy characteristics and maternal breast cancer risk: a review of the epidemiologic literature. Cancer Causes Control (2010) 1.01
Bisphenol-A and diethylstilbestrol exposure induces the expression of breast cancer associated long noncoding RNA HOTAIR in vitro and in vivo. J Steroid Biochem Mol Biol (2014) 1.01
Pregnancy weight gain and breast cancer risk. BMC Womens Health (2004) 0.98
Exposure to diethylstilbestrol during sensitive life stages: a legacy of heritable health effects. Birth Defects Res C Embryo Today (2013) 0.96
Dietary fat intake and gestational weight gain in relation to estradiol and progesterone plasma levels during pregnancy: a longitudinal study in Swedish women. BMC Womens Health (2009) 0.94
Long-term relationship of ovulation-stimulating drugs to breast cancer risk. Cancer Epidemiol Biomarkers Prev (2014) 0.88
Molecular mechanism(s) of endocrine-disrupting chemicals and their potent oestrogenicity in diverse cells and tissues that express oestrogen receptors. J Cell Mol Med (2012) 0.83
Exposure assessment for endocrine disruptors: some considerations in the design of studies. Environ Health Perspect (2003) 0.81
Breast cancer screening in women exposed in utero to diethylstilbestrol. J Womens Health (Larchmt) (2009) 0.81
Effects of early life exposure to methylmercury in Daphnia pulex on standard and reduced food ration. Reprod Toxicol (2014) 0.80
Diverse animal models to examine potential role(s) and mechanism of endocrine disrupting chemicals on the tumor progression and prevention: Do they have tumorigenic or anti-tumorigenic property? Lab Anim Res (2011) 0.78
Mortality in women given diethylstilbestrol during pregnancy. Br J Cancer (2006) 0.77
Factors associated with a lack of pap smear utilization in women exposed in utero to diethylstilbestrol. J Womens Health (Larchmt) (2015) 0.75
Evaluation of different wastewater treatment techniques in three WWTPs in Istanbul for the removal of selected EDCs in liquid phase. Environ Monit Assess (2013) 0.75
Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med (1971) 11.95
The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med (1995) 11.08
Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA (2000) 7.77
Endometrial cancer and estrogen use. Report of a large case-control study. N Engl J Med (1979) 2.19
A twenty-five-year follow-up study of women exposed to diethylstilbestrol during pregnancy. N Engl J Med (1978) 1.95
Does the administration of diethylstilbestrol during pregnancy have therapeutic value? Am J Obstet Gynecol (1953) 1.64
Breast cancer in mothers given diethylstilbestrol in pregnancy. N Engl J Med (1984) 1.58
Randomised trial of high doses of stilboestrol and ethisterone in pregnancy: long-term follow-up of mothers. Br Med J (1980) 1.42
Diethylstilbestrol usage: Its interesting past, important present, and questionable future. Med Clin North Am (1974) 1.26
Breast cancer in mothers prescribed diethylstilbestrol in pregnancy. Further follow-up. JAMA (1993) 1.05
Diethylstilbestrol and risk of fatal breast cancer in a prospective cohort of US women. Am J Epidemiol (1996) 1.01
Cancer of the uterine corpus after hormonal treatment for breast cancer. Lancet (1976) 1.01
Stilboestrol (diethylstilbestrol) and the risk of ovarian cancer. Lancet (1977) 1.01
Cancer risk among women exposed to exogenous estrogens during pregnancy. J Natl Cancer Inst (1984) 0.97
A randomized double-blind controlled trial of the value of stilboestrol therapy in pregnancy: long-term follow-up of mothers and their offspring. Br J Obstet Gynaecol (1983) 0.95
Diethylstilbestrol and the risk of cancer. N Engl J Med (1979) 0.84
The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med (1997) 13.96
Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med (1971) 11.95
Assembly of microarrays for genome-wide measurement of DNA copy number. Nat Genet (2001) 11.06
Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst (1993) 9.48
Residential exposure to magnetic fields and acute lymphoblastic leukemia in children. N Engl J Med (1997) 6.72
Cellular-telephone use and brain tumors. N Engl J Med (2001) 5.57
Lactation and a reduced risk of premenopausal breast cancer. N Engl J Med (1994) 5.37
Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control Clin Trials (2000) 5.37
Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst (1993) 5.07
Solid cancers after bone marrow transplantation. N Engl J Med (1997) 4.62
A controlled trial of diazepam administered during febrile illnesses to prevent recurrence of febrile seizures. N Engl J Med (1993) 4.44
Characterization of the imitation switch subfamily of ATP-dependent chromatin-remodeling factors in Saccharomyces cerevisiae. Genes Dev (1999) 4.25
Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. N Engl J Med (1999) 4.11
Statewide study of diagnostic agreement in breast pathology. J Natl Cancer Inst (1998) 3.77
Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. J Natl Cancer Inst (1996) 3.76
The Framingham Eye Study. I. Outline and major prevalence findings. Am J Epidemiol (1977) 3.73
Population-based study of risk of breast cancer in carriers of BRCA2 mutation. Lancet (1998) 3.61
Benzene and the dose-related incidence of hematologic neoplasms in China. Chinese Academy of Preventive Medicine--National Cancer Institute Benzene Study Group. J Natl Cancer Inst (1997) 3.61
Validation studies using an alloyed gold standard. Am J Epidemiol (1993) 3.56
The role of biostatistics in the prevention, detection and treatment of fraud in clinical trials. Stat Med (1999) 3.53
Occupational therapy for independent-living older adults. A randomized controlled trial. JAMA (1997) 3.47
Adenocarcinoma and Barrett's esophagus. An overrated risk? Gastroenterology (1984) 3.36
Prevention of childhood injuries: evaluation of the Statewide Childhood Injury Prevention Program (SCIPP). Am J Public Health (1989) 3.17
Prevalence of senile cataract, diabetic retinopathy, senile macular degeneration, and open-angle glaucoma in the Framingham eye study. Am J Ophthalmol (1978) 3.14
Pregnancy termination in relation to risk of breast cancer. JAMA (1996) 3.04
Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst (1995) 3.03
Changes in prostate cancer incidence and treatment in USA. Lancet (1994) 3.01
Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst (2001) 2.73
Interim guidelines for management of abnormal cervical cytology. The 1992 National Cancer Institute Workshop. JAMA (1994) 2.71
Fraud in medical research: an international survey of biostatisticians. ISCB Subcommittee on Fraud. Control Clin Trials (2000) 2.67
Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer (1999) 2.66
Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma. JAMA (1997) 2.65
Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood (1999) 2.65
A comparison of pregnancy history recall and medical records. Implications for retrospective studies. Am J Epidemiol (1985) 2.65
Random digit dialing in selecting a population-based control group. Am J Epidemiol (1984) 2.64
A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer (2005) 2.62
The emerging epidemic of melanoma and squamous cell skin cancer. JAMA (1989) 2.61
Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 clinical trial. Neurology (2012) 2.54
Dog bites of the face: a 15 year review. Br J Plast Surg (1983) 2.51
Protection against allergen-induced asthma by salmeterol. Lancet (1990) 2.51
Diagnosis of equine monocytic ehrlichiosis (Potomac horse fever) by indirect immunofluorescence. J Am Vet Med Assoc (1986) 2.49
Mammographic densities and risk of breast cancer. Cancer (1991) 2.47
Attributable risk: advantages of a broad definition of exposure. Am J Epidemiol (1994) 2.45
Adenocarcinoma of the vagina in adolescence. A report of 7 cases including 6 clear-cell carcinomas (so-called mesonephromas). Cancer (1970) 2.44
Artificial sweeteners and human bladder cancer. Preliminary results. Lancet (1980) 2.42
Intra-abdominal hypertension and abdominal compartment syndrome in burn patients. J Trauma (2000) 2.42
An assessment of prostatectomy for benign urinary tract obstruction. Geographic variations and the evaluation of medical care outcomes. JAMA (1988) 2.42
Capture-recapture methods for assessing the completeness of case ascertainment when using multiple information sources. J Chronic Dis (1974) 2.38
Risk of leukemia after chemotherapy and radiation treatment for breast cancer. N Engl J Med (1992) 2.34
The APCI1307K allele and cancer risk in a community-based study of Ashkenazi Jews. Nat Genet (1998) 2.32
The Framingham Eye Study. II. Association of ophthalmic pathology with single variables previously measured in the Framingham Heart Study. Am J Epidemiol (1977) 2.28
The requirement for macrophages in the in vitro immune response. Cell Immunol (1971) 2.24
Inputs into coronary care during 30 years. A cost effectiveness study. Ann Intern Med (1974) 2.24
Fluoridated drinking water and the occurrence of cancer. J Natl Cancer Inst (1976) 2.19
Non-differential misclassification and bias towards the null: a clarification. Occup Environ Med (1995) 2.15
Leukemia after therapy with alkylating agents for childhood cancer. J Natl Cancer Inst (1987) 2.12
Clear-cell adenocarcinoma of the genital tract in young females. Registry report. N Engl J Med (1972) 2.11
Extra-hepatic manifestations of autochthonous hepatitis E infection. Aliment Pharmacol Ther (2014) 2.11
Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation. N Engl J Med (2001) 2.11
Somatostatin: hypothalamic inhibitor of the endocrine pancreas. Science (1974) 2.11
Mortality from leukaemia and cancer in shipyard nuclear workers. Lancet (1978) 2.08
Avoiding serious infections associated with abdominal hysterectomy: a meta-analysis of antibiotic prophylaxis. Am J Obstet Gynecol (1993) 2.07
Extended duration of herpes simplex virus DNA in genital lesions detected by the polymerase chain reaction. J Infect Dis (1991) 2.06
Distal anterior compartment myopathy: a dysferlin mutation causing a new muscular dystrophy phenotype. Ann Neurol (2001) 2.05
Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA. New Hampshire Skin Cancer Study Group. Int J Cancer (1999) 2.04
Incidence of familial melanoma and MLM2 gene. Lancet (1994) 2.03
Geographic variation in mortality from breast cancer among white women in the United States. J Natl Cancer Inst (1995) 2.03
A twenty-five-year follow-up study of women exposed to diethylstilbestrol during pregnancy. N Engl J Med (1978) 1.95
Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo-controlled trial. Crit Care Med (1999) 1.92
Dietary and nutritional factors and pancreatic cancer: a case-control study based on direct interviews. J Natl Cancer Inst (1998) 1.91
Antioxidant vitamins, cancer, and cardiovascular disease. N Engl J Med (1996) 1.90
Early inhaled glucocorticoid therapy to prevent bronchopulmonary dysplasia. N Engl J Med (1999) 1.89
Opening propofol ampoules. Anaesthesia (1998) 1.88
Alcohol consumption and breast cancer in the epidemiologic follow-up study of the first National Health and Nutrition Examination Survey. N Engl J Med (1987) 1.87
Lung cancer and the debrisoquine metabolic phenotype. J Natl Cancer Inst (1990) 1.86
Are children living near high-voltage power lines at increased risk of acute lymphoblastic leukemia? Am J Epidemiol (2000) 1.82
Breast cancer risk factors among screening program participants. J Natl Cancer Inst (1979) 1.81
Household solvent exposures and childhood acute lymphoblastic leukemia. Am J Public Health (2001) 1.80
Skin cancer risk in relation to toenail arsenic concentrations in a US population-based case-control study. Am J Epidemiol (2001) 1.80
A nested case-control study of non-Hodgkin lymphoma and serum organochlorine residues. Lancet (1997) 1.79
Reproductive, menstrual, and medical risk factors for endometrial cancer: results from a case-control study. Am J Obstet Gynecol (1992) 1.77
Bladder cancer, drinking water source, and tap water consumption: a case-control study. J Natl Cancer Inst (1987) 1.77
Diethylstilbestrol revisited: a review of the long-term health effects. Ann Intern Med (1995) 1.76
Alcohol consumption and breast cancer risk among women under age 45 years. Epidemiology (1997) 1.76
Case-control study of endogenous steroid hormones and endometrial cancer. J Natl Cancer Inst (1996) 1.76
Sexual behaviour, STDs and risks for prostate cancer. Br J Cancer (2000) 1.73
A prospective randomized trial of outpatient versus inpatient cardiac catheterization. N Engl J Med (1988) 1.73
Cigarette smoking and pancreas cancer: a case-control study based on direct interviews. J Natl Cancer Inst (1994) 1.73
Evidence of a healthy estrogen user survivor effect. Epidemiology (1995) 1.72
Urinary tract infection and risk of bladder cancer. Am J Epidemiol (1984) 1.70
Specific genomic markers for the HLA-DQ subregion discriminate between DR4+ insulin-dependent diabetes mellitus and DR4+ seropositive juvenile rheumatoid arthritis. J Exp Med (1986) 1.69
Pedestrian crashes: higher injury severity and mortality rate for light truck vehicles compared with passenger vehicles. Inj Prev (2004) 1.67
Proficiency testing in parasitology. An educational tool to improve laboratory performance. Am J Clin Pathol (1994) 1.65
Substituting diagnostic services. New tests only partly replace older ones. JAMA (1989) 1.64
Sunlight exposure as risk factor for intraocular malignant melanoma. N Engl J Med (1985) 1.64